β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 105
14 JULY 2011
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan France, Pringy, France
Product: Oralcon 30
Active Ingredients: Ethinylestradiol 0.0306mg
Levonorgestrel 0.15mg
Dosage Form: Tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Famy Care Limited, Gujarat, India
Product: Oralcon 30 ED
Active Ingredients: Ethinylestradiol 0.0306mg
Levonorgestrel 0.15mg
Dosage Form: Tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Famy Care Limited, Gujarat, India
Product: Quetiapine Pfizer
Active Ingredient: Quetiapine fumarate 28.78mg equivalent to quetiapine 25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Aurobindo Pharma Limited, Hyderabad, India
Product: Quetiapine Pfizer
Active Ingredient: Quetiapine fumarate 115.122mg equivalent to quetiapine 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Aurobindo Pharma Limited, Hyderabad, India
Product: Quetiapine Pfizer
Active Ingredient: Quetiapine fumarate 172.683mg equivalent to quetiapine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Aurobindo Pharma Limited, Hyderabad, India
Product: Quetiapine Pfizer
Active Ingredient: Quetiapine fumarate 230.244mg equivalent to quetiapine 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Aurobindo Pharma Limited, Hyderabad, India
Product: Quetiapine Pfizer
Active Ingredient: Quetiapine fumarate 345.366mg equivalent to quetiapine 300mg
Dosage Form: Film coated tablet
Dated this 7th day of July 2011.
STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go4707
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Diovan
Active Ingredient: Valsartan 40mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland
Product: Diovan
Active Ingredient: Valsartan 80mg
Dosage Form: Film coated tablet
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare7 July 2011
Medicines Act, New Medicines, Oralcon 30, Quetiapine Pfizer, Ethinylestradiol, Levonorgestrel, Valsartan
- STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2011, No 105